XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 6,347 $ 7,192 $ 14,836 $ 11,259
General and administrative 12,924 11,867 26,047 26,997
Total operating expenses 19,271 19,059 40,883 38,256
Loss from operations (19,271) (19,059) (40,883) (38,256)
Other income (expense):        
Interest income, net 4,129 465 8,269 488
Gain on change in fair value of Sponsor Earn-Out Liability, net 2,926 28,958 3,495 21,270
Other income (expense), net (405) (1,171) 415 (1,331)
Total other income (expense), net 6,650 28,252 12,179 20,427
(Loss) income before income taxes (12,621) 9,193 (28,704) (17,829)
Provision for income taxes (327) (178) (470) (189)
Net (loss) income (12,948) 9,015 (29,174) (18,018)
Other comprehensive (loss) income:        
Unrealized loss on investments (721)   (254)  
Foreign currency translation adjustment (1,492) (1,377) (1,420) (1,268)
Total comprehensive (loss) income $ (15,161) $ 7,638 $ (30,848) $ (19,286)
Net (loss) gain per share attributable to common stockholders, basic (in dollars per share) $ (0.04) $ 0.03 $ (0.09) $ (0.07)
Net (loss) gain per share attributable to common stockholders, diluted (in dollars per share) $ (0.04) $ 0.03 $ (0.09) $ (0.07)
Weighted-average common shares outstanding, basic (in shares) 314,578,498 310,255,853 314,003,663 264,969,675
Weighted-average common shares outstanding, diluted (in shares) 314,578,498 310,255,853 314,003,663 264,969,675